Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;25(2):175-9.
doi: 10.1016/j.sjopt.2011.01.006. Epub 2011 Jan 28.

Pascal laser versus conventional laser for treatment of diabetic retinopathy

Abdelrahman G Salman  1
Affiliations

Pascal laser versus conventional laser for treatment of diabetic retinopathy

Abdelrahman G Salman. Saudi J Ophthalmol. 2011 Apr.

Abstract

Purpose: To compare the safety and efficacy of Pascal laser photocoagulation in comparison with the conventional laser photocoagulation in the treatment of diabetic retinopathy.

Patients and methods: A prospective randomized case series study was done on 120 procedures done in 120 patients divided into two main groups, group A, patients undergoing focal or modified grid macular laser and group B, patients undergoing panretinal photocoagulation (PRP). Each of the two groups were subdivided into two subgroups randomly in the first we used conventional laser photocoagulation (groups A1 and B1) and in the other we used Pascal laser photocoagulation (groups A2 and B2).

Results: Procedures in groups A1,2 and in groups B1,2 had successful outcomes. Significantly higher powers were required with the Pascal (groups A2 and B2) than with conventional laser (groups A1 and B1) (p < 0.001) in eyes that underwent PRP and focal/modified grid macular treatment with both systems. No adverse events were noted in all groups.

Conclusion: The Pascal photocoagulator is safe, rapid, effective, with rapid learning and had short exposure time. Although the shorter pulse duration of the Pascal necessitates the use of a higher power, it is not associated with adverse effects.

Keywords: Conventional laser; Diabetic retinopathy; Pascal laser.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Modified grid by conventional laser. (B) PRP for PDR with combined conventional laser and Pascal photocoagulation for comparison.
Figure 2
Figure 2
Combined PRP and modified grid by Pascal laser.
See this image and copyright information in PMC

References

    1. ANSI . American National Standards Institute; Orlando, FL: 2000. Safe Use of Lasers. [Z-136.1-2000]
    1. Bailey C.C., Sparrow J.M., Grey R.H. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes. Eye. 1999;13:151–159. - PubMed
    1. Blumenkranz M.S., Yellachich D., Andersen D.E. Semiautomated patterned scanning laser for retinal photocoagulation. Retina. 2006;26:370–376. - PubMed
    1. Brinkmann R., Huettmann G., Rogener J. Origin of retinal pigment epithelium cell damage by pulsed laser irradiance in the nanosecond to microsecond time regimen. Lasers Surg. Med. 2000;27:451–464. - PubMed
    1. Cordeiro M.F., Stanford M.R., Phillips P.M. Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye. 1997;11:531–536. - PubMed